IP Library Granted Patent US 9,371,531
Granted Patent B2
US 9,371,531 · App. 13/740,337 · Granted Jun 21, 2016

Vectors for directional cloning

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,371,531
App. No.
13/740,337
Granted
Jun 21, 2016
Kind
B2
Abstract

The invention provides vectors and methods for directional cloning.

Claims (9)

1. A vector encoding a fusion polypeptide prepared by ligating

a DNA fragment comprising a first open reading frame that begins with start codon but does not end with an in-frame stop codon, a 5′ end generated after cleavage of a first recognition site with a first restriction enzyme which generates an end compatible with an end generated after cleavage of a SgfI recognition site by SgfI, and a 3′ end generated after cleavage of a second recognition site with a second restriction enzyme that generates a blunt end, and

a DNA segment comprising a second open reading frame which ends with a stop codon, a 3′ end generated after cleavage of a third recognition site with a third restriction enzyme which generates an end compatible with an end generated after cleavage of a SgfI recognition site by SgfI, a 5′ end generated after cleavage of a fourth recognition site for a fourth restriction enzyme which generates a blunt end, and a promoter located at the 3′ end of the DNA segment and between the stop codon and the third recognition site,

wherein the first recognition site is cleaved by SgfI, the third recognition site is cleaved by SgfI or both the first and third recognition sites are cleaved by SgfI, wherein ligation of the blunt ends yields a third open reading frame comprising the first and second open reading frames which encodes the fusion polypeptide, wherein the promoter is 5′ to and operably linked to the first open reading frame following the ligation of the first recognition site and the third recognition site, wherein a SgfI site is located between the promoter and the first open reading frame following the ligation of the first recognition site and the third recognition site, and wherein the first and third recognition sites are cleaved by SgfI and yield i) an exchange site comprising GCGATCGCnATGG (SEQ ID NO: 92), wherein n is C, A, T or G, or ii) an exchange site comprising GCGATCGCnATG (SEQ ID NO: 93), wherein n is C, A, T or G.

2. The vector of claim 1 wherein the second restriction enzyme is PmeI.

3. The vector of claim 1 wherein the fourth restriction enzyme is not PmeI.

4. The vector of claim 1 wherein the second restriction enzyme is PmeI and the fourth restriction enzyme is not PmeI.

5. The vector of claim 1 , wherein the second open reading frame does not begin with a start codon.

6. The vector of claim 1 , wherein the fourth restriction enzyme is EcoICRI.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2013
From: SLATER, MICHAEL R.; STRAUSS, ETHAN EDWARD; WOOD, KEITH V.; HARTNETT, JAMES ROBERT
To: PROMEGA CORPORATION
Reel/Frame 029654/0978 →